Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Identify which index fund to hold after IRA rollover 2024 by weighing cost, simplicity, and diversification. Get practical guidance for a solid retirement stance.
26,517 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Two tech giants stand out for investors seeking value in megacap stocks. This guide breaks down strengths, risks, and...
Anthropic, the Claude-maker, confidentially files to go public, igniting talk of a potential trillion-dollar valuatio...
A multistate settlement with Block, the company behind Cash App, brings money back to consumers including Minnesota. ...
When a hedge fund disclosed a sizable new stake in Asbury Automotive, the market reacted. This guide breaks down why ...
Cloud giants are expanding, yet the super micro computer stock slid on a capital-raise plan. This article breaks down...
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
The broadcom sell-off: this huge moment is more than a single stock move. It underscores how AI optimism meets market...
Investors are shifting from traditional savings toward monthly dividend ETFs offering higher yields. This report brea...
Oneok beat quarterly expectations but issued soft 2026 guidance, sending shares lower. This article explains why oneo...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...
A celebrity-led passion project climbs to the top on Apple TV, proving that owning your story and diversifying income...